 |
Nitroprusside |
|---|---|
| Trade Name | |
| Orphan Indication | Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage |
| USA Market Approval | USA |
| USA Designation Date | 2001-02-21 00:00:00 |
| Sponsor | Thomas, MD, Jeffrey Evan;Thomas Jefferson University and Wills Neurosensory, 834 Walnut Street, Suite 650;Philadelphia, Pennsylvania, 19107 |
